NSB 12.8% 3.4¢ neuroscientific biopharmaceuticals ltd

Ann: EmtinB Can Become a Revolutionary Treatment for Glaucoma, page-25

  1. 11,118 Posts.
    lightbulb Created with Sketch. 499
    Bots all over this... its very undervalued, especially considering Alz update should be out shortly.
 
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.